Concord Biotech Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| CONCORDBIO.NS | BIOCON.NS | 1177.HK | 1548.HK | 0A3M.IL | INSM | |
|---|---|---|---|---|---|---|
| Market cap | 132.86B | 548.65B | 95.24B | 78.27B | 25.10B | 20.54B |
| P/E (TTM) | 43.7 | 99.1 | 35.7 | — | 5.1 | — |
| Forward P/E | 29.8 | 30.6 | 17.0 | 87.5 | 5.1 | 112.7 |
| Price/book | 6.6 | 1.6 | 2.5 | 2.5 | 1.1 | 27.1 |
| Dividend yield | 0.59% | 0.15% | 2.59% | — | — | — |
| 1-year change | −15.54% | −7.13% | −25.00% | +106.04% | −15.17% | −40.36% |
| Today | −1.23% | −1.47% | −0.93% | +2.69% | +1.96% | −1.70% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All CONCORDBIO.NS news ›Concord Biotech CONCORDBIO Reg 74(5) Certificate Q2 FY27
Kalkine India Concord Biotech (NSE:CONCORDBIO): What Does Its Reg 74(5) Certificate Mean? Source: Krish Capital Pty Ltd Concord Biotech Limited (NSE:CONCORDBIO) submitted a compliance certificate on 07 October 2026 to both NSE and BSE,…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
inshorts.com1
-
kalkine.co.in1
-
livemint.com1
-
tradebrains.in1
-
tradingview.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 6 articles, not a forecast.